| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11018896 | Neurología | 2018 | 6 Pages |
Abstract
The beneficial effects of OnabotA for CM continue over time. OnabotA is a safe and well-tolerated treatment whose use for refractory CM should not be delayed since early treatment provides greater benefits.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
A. Castrillo Sanz, N. Morollón Sánchez-Mateos, C. Simonet Hernández, B. Fernández RodrÃguez, D. Cerdán Santacruz, A. Mendoza RodrÃguez, M.F. RodrÃguez Sanz, C. Tabernero GarcÃa, P. Guerrero Becerra, M. Ferrero Ros, J. Duate GarcÃa-Luis,